结肠直肠癌早期诊断中DNA甲基化检测的研究进展

摘要/Abstract

中图分类号:

胡育铭, 郑阔, 于冠宇, 张卫. 结肠直肠癌早期诊断中DNA甲基化检测的研究进展[J]. 外科理论与实践, 2019, 24(04): 367-370.

[1] Siegel R, Desantis C, Jemal A.Colorectal cancer statistics, 2014[J]. CA Cancer J Clin,2014,64(2):104-117.
[2] Ferlay J, Shin HR, Bray F, et al.Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008[J]. Int J Cancer,2010,127(12):2893-2917.
[3] 顾晋, 汪建平, 孙燕, 等. 中国结直肠癌诊疗规范(2017年版)[J]. 中华临床医师杂志(电子版),2018,12(1):3-23.
[4] Siegel RL, Miller KD, Fedewa SA, et al.Colorectal cancer statistics, 2017[J]. CA Cancer J Clin,2017,67(3):104-117.
[5] Brenner H, Chang-Claude J, Jansen L, et al.Reduced risk of colorectal cancer up to 10 years after screening, surveillance, or diagnostic colonoscopy[J]. Gastroentero-logy,2014,146(3):709-717.
[6] Walker DP, Rogier DJ. European guidelines for quality assurance in colorectal cancer screening and diagnosis. First Edition-Annotations of colorectal lesions[J]. Endoscopy,2012,44(Suppl 3):SE131-SE139.
[7] Shaukat A, Mongin SJ, Geisser MS, et al.Long-term mortality after screening for colorectal cancer[J]. N Engl J Med,2013,369(12):1106-1114.
[8] Kaminski MF, Regula J, Kraszewska E, et al.Quality indicators for colonoscopy and the risk of interval cancer[J]. N Engl J Med,2010,362(19):1795-1803.
[9] Binefa G, Rodríguez-Moranta F, Teule A, et al.Colorectal cancer: From prevention to personalized medicine[J]. World J Gastroenterol,2014,20(22):6786-6808.
[10] Chen CC, Yang SH, Lin JK, et al.Is it reasonable to add preoperative serum level of CEA and CA19-9 to staging for colorectal cancer?[J]. J Surg Res,2005,124(2):169-174.
[11] Othman M, Agüero R, Lin HC.Alterations in intestinal microbial flora and human disease[J]. Curr Opin Gastroenterol,2008,24(1):11-16.
[12] Sansonetti PJ, Medzhitov R.Learning tolerance while fighting ignorance[J]. Cell,2009,138(3):416-420.
[13] Vymetalkova V, Cervena K, Bartu L, et al. Circulating cell-free DNA and colorectal cancer: a systematic review[J]. Int J Mol Sci,2018,19(11). pii: E3356.
[14] Danese E, Minicozzi AM, Benati M, et al.Epigenetic alteration: new insights moving from tissue to plasma-the example of PCDH10 promoter methylation in colorectal cancer[J]. Br J Cancer,2013,109(3):807-813.
[15] 王瑞娴, 徐建红. 基因组DNA甲基化及组蛋白甲基化[J]. 遗传,2014,36(3):191-199.
[16] Matrisciano F, Panaccione I, Dong E, et al.Epigenetics: from basic biology to chromatin-modifying drugs and new potential clinical applications[M]// Nina K, Epigenetic Methods in Neuroscience Research. New York: Humana Press,2016:3-18.
[17] Fearon ER, Vogelstein B.A genetic model for colorectal tumorigenesis[J]. Cell,1990,61(5):759-767.
[18] Vogelstein B, Fearon ER, Hamilton SR, et al.Genetic alterations during colorectal-tumor development[J]. N Engl J Med,1988,319(9):525-532.
[19] Kuipers EJ.Colorectal cancer[J]. Nat Rev Dis Primers,2015,1:15065.
[20] Weitz J, Koch M, Debus J, et al.Colorectal cancer[J]. Lancet,2004,365(9454):153-165.
[21] Haydon AM, Jass JR.Emerging pathways in colorectal-cancer development[J]. Lancet Oncol,2002,3(2):83-88.
[22] Yiu AJ, Yiu CY.Biomarkers in colorectal cancer[J]. Co-lorectal Dis,2016,36(3):1093-1102.
[23] Gervaz P, Cerottini JP, Bouzourene H, et al.Comparison of microsatellite instability and chromosomal instability in predicting survival of patients with T3N0 colorectal cancer[J]. Surgery,2002,131(2):190-197.
[24] Gervaz P, Bucher P, Morel P.Two colons-two cancers: Paradigm shift and clinical implications[J]. J Surg Oncol,2004,88(4):261-266.
[25] Pinto AE, Chaves P, Fidalgo P, et al.Flow cytometric DNA ploidy and S-phase fraction correlate with histopathologic indicators of tumor behavior in colorectal carcinoma[J]. Dis Colon Rectum,1997,40(4):411-419.
[26] Goel A, Nagasaka T, Arnold CN, et al.The CpG island methylator phenotype and chromosomal instability are inversely correlated in sporadic colorectal cancer[J]. Gastroenterology,2007,132(1):127-138.
[27] Migheli F, Migliore L.Epigenetics of colorectal cancer[J]. Clin Genet,2012,81(4):312-318.
[28] Herman JG, Baylin SB.Gene silencing in cancer in association with promoter hypermethylation[J]. N Engl J Med,2003,349(21):2042-2054.
[29] Puccini A, Berger MD, Naseem M, et al.Colorectal cancer: Epigenetic alterations and their clinical implications[J]. Biochim Biophys Acta Rev Cancer,2017,1868(2):439-448.
[30] Herman JG, Graff JR, Myöhänen S, et al.Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands[J]. Proc Natl Acad Sci U S A,1996,93(18):9821-9826.
[31] Kristensen LS, Mikeska T, Krypuy M, et al.Sensitive melting analysis after real time- methylation specific PCR (SMART-MSP): high-throughput and probe-free quantitative DNA methylation detection[J]. Nucleic Acids Res,2008,36(7):e42.
[32] Li M, Chen WD, Papadopoulos N, et al.Sensitive digital quantification of DNA methylation in clinical samples[J]. Nat Biotechnol,2009,27(9):858-863.
[33] Leary RJ, Sausen M, Kinde I, et al. Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing[J]. Sci Transl Med,2012, 4(162):162ra154.
[34] Grützmann R, Molnar B, Pilarsky C, et al.Sensitive detection of colorectal cancer in peripheral blood by septin 9 DNA methylation assay[J]. PLoS One,2008,3(11):e3759.
[35] Church TR, Wandell M, Loftonday C, et al.Prospective evaluation of methylated SEPT9 in plasma for detection of asymptomatic colorectal cancer[J]. Gut,2014,63(2):317-325.
[36] Fu B, Yan P, Zhang S, et al.Cell-free circulating methylated SEPT9 for noninvasive diagnosis and monitoring of colorectal cancer[J]. Dis Markers,2018,2018:6437104.
[37] Ladefoged RS, Bygum KH, Gotschalck SK, et al.Hypermethylated DNA, a circulating biomarker for colorectal cancer detection[J]. PLoS One,2017,12(7):e0180809.
[38] Ahlquist DA, Taylor WR, Mahoney DW, et al.The stool DNA test is more accurate than the plasma septin 9 test in detecting colorectal neoplasia[J]. Clin Gastroenterol Hepatol,2012,10(3):272-277.
[39] Symonds EL, Pedersen SK, Murray DH, et al.Circulating tumour DNA for monitoring colorectal cancer-a prospective cohort study to assess relationship to tissue methylation, cancer characteristics and surgical resection[J]. Clin Epigenetics,2018,10:63.
[40] Carmona FJ, Azuara D, Berenguerllergo A, et al.DNA methylation biomarkers for noninvasive diagnosis of co-lorectal cancer[J]. Cancer Prev Res (Phila),2013,6(7):656-665.
[41] Cassinotti E, Melson J, Liggett T, et al.DNA methylation patterns in blood of patients with colorectal cancer and adenomatous colorectal polyps[J]. Int J Cancer,2012,131(5):1153-1157
[42] Schwarzenbach H, Stoehlmacher J, Pantel K, et al.Detection and monitoring of cell-free DNA in blood of patients with colorectal cancer[J]. Ann N Y Acad Sci,2008, 1137(1):190-196.
[43] Jung M, Klotzek S, Lewandowski M, et al.Changes in concentration of DNA in serum and plasma during sto-rage of blood samples[J]. Clin Chem,2003,49(1):1028-1029.

结肠直肠癌早期诊断中DNA甲基化检测的研究进展

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章15

编辑推荐

Metrics

本文评价

[1]	许勇, 蔡云泽, 宋林.基于数据驱动的核电设备状态评估研究综述[J]. 开云网页登录学报, 2022, 56(3): 267-278.
[2]	刘秀丽, 徐小力.基于特征金字塔卷积循环神经网络的故障诊断方法[J]. 开云网页登录学报, 2022, 56(2): 182-190.
[3]	马航宇, 周笛, 卫宇杰, 吴伟, 潘尔顺.变工况下基于自适应深度置信网络的轴承智能故障诊断[J]. 开云网页登录学报, 2022, 56(10): 1368-1377.
[4]	黄蔚, 李恒宇, 丁晓毅.晚期乳腺癌介入诊疗的价值及应用[J]. 外科理论与实践, 2022, 27(05): 411-415.
[5]	陈宏, 沈银忠.人类免疫缺陷病毒感染/艾滋病合并结核病的诊治进展[J]. 诊断学理论与实践, 2022, 21(04): 530-534.
[6]	何新, 陈慧, 冯炜炜.机器学习算法在辅助超声诊断附件肿块良恶性中的应用研究进展[J]. 诊断学理论与实践, 2022, 21(04): 541-546.
[7]	徐子真, 李擎天, 刘湘帆, 李莉, 李惠, 王也飞, 吴洁敏, 陈宁, 梁璆荔, 陈松立, 戴健敏, 宋珍, 丁磊.实验诊断学在线课程的建立和实践[J]. 诊断学理论与实践, 2022, 21(04): 547-550.
[8]	陈志敏, 何浩岚.艾滋病合并马尔尼菲篮状菌病的诊治现状[J]. 诊断学理论与实践, 2022, 21(04): 425-430.
[9]	沈银忠.《人类免疫缺陷病毒感染/艾滋病合并结核分枝杆菌感染诊治专家共识》解读[J]. 诊断学理论与实践, 2022, 21(04): 431-436.
[10]	邹峻, 管剑龙.白塞综合征临床表型分类和研究进展[J]. 内科理论与实践, 2022, 17(03): 195-197.
[11]	王凡, 叶俊娜, 杨程德.回纹型风湿症的诊断与治疗进展[J]. 内科理论与实践, 2022, 17(03): 258-261.
[12]	赵然, 詹维伟, 侯怡卿.计算机辅助诊断系统辅助超声诊断甲状腺弥漫性病变合并结节良恶性的应用价值[J]. 诊断学理论与实践, 2022, 21(03): 390-394.
[13]	郭业兵, 郑金峰.阴道壁胃肠道外间质瘤一例报道并文献复习[J]. 诊断学理论与实践, 2022, 21(03): 405-407.
[14]	包全, 邢宝才.复杂双叶多发性结肠直肠癌肝转移外科治疗策略[J]. 外科理论与实践, 2022, 27(02): 128-130.
[15]	王贵福, 刘仁杰, 柏斗胜, 蒋国庆, 张弛, 王谦, 王翱卿, 金圣杰.胆石性肠梗阻的诊断与治疗[J]. 外科理论与实践, 2022, 27(02): 169-172.